Birmingham, Clarkston, Lake Orion (PRWEB) July 18, 2017
Women’s Excellence now offers an in-depth genetic evaluation in order to detect mutations of the BRCA1 and BRCA2 genes. Breast cancer and other cancers in women have been related to genetic markers. Over the years, scientific research has been able to identify these abnormalities. There are now ways to identify patients’ risk of developing a feminine cancer.
Specific inherited mutations in BRCA1 and BRCA2 increase the risk of female breast and ovarian cancers and they have been associated with increased risks of several additional types of cancer. Together, BRCA1 and BRCA2 mutations account for about 20 to 25 percent of hereditary breast cancers and about 5 to 10 percent of all breast cancers.
Women’s Excellence is the most comprehensive obstetric and gynecologic office in Michigan. Additionally, they specialize in menopause, weight control, bladder control, endometriosis, robotic surgery and midwifery services. Women’s Excellence is committed to staying at the forefront of innovation with cutting edge technologies utilizing robotic surgery and minimally invasive surgical options when possible. The knowledgeable, compassionate physicians and healthcare providers of Women’s Excellence focus on patient-centered processes to deliver the highest quality of care. They are affiliated with most insurances. They offer seamless medical record access via a state of the art patient portal and use the latest technology for record keeping and sharing, making the patient experience easier and more efficient. Women’s Excellence is taking new patients and is conveniently located in three locations throughout southeastern Michigan, Birmingham, Lake Orion, and Clarkston. For more information, visit http://www.WomensExcellence.com.